Company Filing History:
Years Active: 2024
Title: Hyun Chul An: Innovator in Influenza Treatment
Introduction
Hyun Chul An is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing influenza virus diseases. His innovative approach has the potential to improve therapeutic options for patients suffering from these illnesses.
Latest Patents
Hyun Chul An holds a patent for a dosing regimen aimed at treating influenza virus diseases. The patent, titled "Dosing regimen for treating influenza virus diseases," focuses on a method that utilizes a mixed composition of monoclonal antibodies with neutralizing activity against the influenza A virus. This treatment method allows for the intravenous administration of these antibodies, addressing unmet medical needs for biological therapeutic agents in the fight against influenza-related diseases. He has 1 patent to his name.
Career Highlights
Hyun Chul An is associated with Celltrion Inc., a company known for its advancements in biopharmaceuticals. His work at Celltrion has positioned him as a key player in the development of innovative treatments for viral infections.
Collaborations
He has collaborated with notable colleagues, including Sung Hyun Kim and Sang Joon Lee, to further enhance the research and development of effective treatments for influenza.
Conclusion
Hyun Chul An's contributions to the field of influenza treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only addresses current health challenges but also paves the way for future developments in antiviral therapies.